Prolonged Amphetamine Treatments Cause Long-Term Decrease of Dopamine Uptake in Cultured Cells

Amphetamine (AMPH) is a systemic stimulant used to treat a variety of diseases including Attention Deficit Hyperactive Disorder, narcolepsy and obesity. Previous data showed that by binding to catecholamine transporters, AMPH prevents the reuptake of the neurotransmitters dopamine (DA) and norepinep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferdous, Nafisa, Kudumala, Sirisha, Sossi, Serena, Carvelli, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260268/
https://www.ncbi.nlm.nih.gov/pubmed/31883055
http://dx.doi.org/10.1007/s11064-019-02938-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260268/
https://www.ncbi.nlm.nih.gov/pubmed/31883055
http://dx.doi.org/10.1007/s11064-019-02938-7

Ejemplares similares